Software Healthcare Sector

Pacific Biosciences of California

Market Cap: US$419.6m

Designs, develops, and manufactures sequencing solutions to resolve genetically complex problems.

vTv Therapeutics

Market Cap: US$413.2m

A late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases.

SBC Medical Group Holdings

Market Cap: US$411.4m

Provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore.

Vogenx

Market Cap: US$410.8m

Operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.

Community Health Systems

Market Cap: US$407.9m

Owns, leases, and operates general acute care hospitals in the United States.

Orthofix Medical

Market Cap: US$407.7m

Operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally.

Phase Holographic Imaging PHI

Market Cap: US$407.3m

A medical technology company, develops and markets non-invasive time-lapse imaging instruments in Sweden and internationally.

X4 Pharmaceuticals

Market Cap: US$400.6m

A biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system.

Lexeo Therapeutics

Market Cap: US$400.4m

A clinical stage genetic medicine company, focuses on hereditary and acquired diseases with high unmet need in the United States.

Fennec Pharmaceuticals

Market Cap: US$395.9m

Operates as a commercial stage biopharmaceutical company in the United States.

Alpha Teknova

Market Cap: US$395.1m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

NIOX Group

Market Cap: UK£288.7m

Engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide.

Australian Clinical Labs

Market Cap: AU$547.7m

Provides pathology diagnostic services in Australia.

Enanta Pharmaceuticals

Market Cap: US$392.3m

A biotechnology company, discovers and develops small molecule drugs for virology and immunology indications.

PureTech Health

Market Cap: UK£286.3m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Auna

Market Cap: US$389.3m

A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.

Rocket Pharmaceuticals

Market Cap: US$385.3m

Operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States.

Arcturus Therapeutics Holdings

Market Cap: US$382.3m

A messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics.

Upstream Bio

Market Cap: US$381.8m

A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.

Lyell Immunopharma

Market Cap: US$380.6m

A clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.

Cogstate

Market Cap: AU$526.6m

A neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide.

Clinuvel Pharmaceuticals

Market Cap: AU$525.5m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Perspective Therapeutics

Market Cap: US$376.7m

A radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.

Century Therapeutics

Market Cap: US$374.8m

A biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases.

Cresco Labs

Market Cap: CA$516.0m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Simulations Plus

Market Cap: US$372.1m

Develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.

Vitalhub

Market Cap: CA$511.1m

Provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally.

Galectin Therapeutics

Market Cap: US$371.1m

A clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer.

Palisade Bio

Market Cap: US$366.0m

A clinical-stage biopharmaceutical company, engages in developing oral phosphodiesterase-4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon in the United States.

Capricor Therapeutics

Market Cap: US$365.7m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Agenus

Market Cap: US$364.2m

A clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally.

Zentalis Pharmaceuticals

Market Cap: US$362.1m

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States.

Optima Health

Market Cap: UK£258.9m

Provides occupational health and wellbeing services for the public and private sectors in the United Kingdom.

Mobia Medical

Market Cap: US$353.2m

Develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions.

DiaMedica Therapeutics

Market Cap: US$351.6m

A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.

Sutro Biopharma

Market Cap: US$348.9m

Operates as an oncology company.